NuCana plc (NCNA) Financials
NCNA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 34.0 million | 7.3 million |
| March 31, 2026 | 36.4 million | 6.8 million |
| Dec. 31, 2025 | 40.0 million | 7.4 million |
| Sept. 30, 2025 | 43.4 million | 8.6 million |
NCNA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -2.6 million | ? |
| March 31, 2026 | -4.3 million | 2.5 million |
| Dec. 31, 2025 | -1.6 million | 1.2 million |
| Sept. 30, 2025 | 1.7 million | 1.2 million |
NCNA Net Income
No data available :(
NCNA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 25.7 million | - | 838803 |
| March 31, 2026 | 28.4 million | - | 897689 |
| Dec. 31, 2025 | 32.5 million | - | 906868 |
| Sept. 30, 2025 | 33.9 million | - | 182823 |
NCNA Shares Outstanding
NCNA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 3.0 million | - | - |
| March 31, 2026 | 101645 | 4.2 million | 2.1 million | - |
| Dec. 31, 2025 | 67190 | 2.3 million | 1.5 million | - |
| Sept. 30, 2025 | 63181 | 2.9 million | 1.9 million | - |
NCNA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | 94548 |
| March 31, 2026 | - | 91721 |
| Dec. 31, 2025 | - | 91516 |
| Sept. 30, 2025 | - | - |
NCNA
Price: $1.14
52 week price:
Earnings Per Share: 65.09 USD
P/E Ratio: 0.02
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 46300
Market Capitalization: 6.9 million